Cannabics Pharmaceuticals Inc. (CNBX) today announced it will begin providing personalized cannabinoid anti-tumor tests for cancer patients. The diagnostic tests are based on liquid biopsies of patients suffering from any kind of cancer. The test uses CTC technology that collects cancer cells from patients' blood samples, and tests their sensitivity to cannabinoid compounds alongside conventional chemotherapy medicine.

Many countries have legalised the use of cannabis or marijuana for medical and recreational use. The use of marijuana for recreational use is still debatable but medical marijuana can be used for many health conditions. The plant is being considered as a miracle herb. However, only 6% of the marijuana studies research its medicinal properties. Marijuana smoking also has negative effects when abused or overused. The user can get addicted and this dependency can lead to emotional and mental issues. Although we are still researching how exactly the herb affects our body, many studies suggest that marijuana has health benefits. Here are some of the health benefits of smoking weed.

The government is considering making it easier for people to access medicinal cannabis.

Associate Health Minister Peter Dunne says he will make an announcement tomorrow, but will not comment ahead of it.

Cannabis-based products are Class B1 controlled drugs. Ministerial approval is required before they can be prescribed, supplied or administered.

Health Minister Jonathan Coleman said that process was too bureaucratic.

"It's a pretty wide-ranging issue. There's a process which [associate Health Minister] Peter Dunne is looking at in terms of making it easier for people to access cannabis-based medicines, so at the moment they need to be signed off in this case by the associate Minister of Health.

Widely seen as a leader in medical cannabis research and development, an Israeli government committee last weekend approved a plan that would allow medical marijuana companies to export products internationally. The legislation could take months to make its way through the Knesset, but it’s already stoking industry and investor interest.

Noah Starr says he has anxiety over upcoming changes to coverage.

A Fredericton veteran is raising money to send veterans to Ottawa to protest against coming changes in coverage for their medical marijuana prescriptions.

Veteran Noah Starr, who was diagnosed with post-traumatic stress disorder after serving in Afghanistan, said the changes to medical marijuana coverage have taken a toll even before they go into effect.

"I already have anxiety about it," said Starr. "I won't lie.

"I know how effective it is for not only myself but for other retired Canadian Forces members."

Starr has launched a GoFundMe campaign to raise money so veterans with marijuana prescriptions for their PTSD can attend a protest scheduled for April 10.

A pair of Democratic lawmakers hopes to move Wisconsin closer to legalizing medical marijuana with the introduction on Monday of two pieces of legislation. 

The first bill would legalize the use of medical marijuana for patients with qualifying conditions. The second would put the question to voters in the form of a nonbinding statewide referendum.

It is the hope of the bill's co-sponsors, Sen. Jon Erpenbach, D-Middleton, and Rep. Chris Taylor, D-Madison, that lawmakers who aren't inclined to support legalizing medicinal use of the drug might be supportive of having voters weigh in through a nonbinding referendum.

Neither proposal is likely to gain traction in the Republican-led Legislature, and Gov. Scott Walker does not support legalizing medical marijuana.

Some doctors believe medical marijuana could be an effective treatment for children with Autism.

The drug treatment is non-euphoric, or would contain low THC levels,  so kids wouldn’t get high.

Under Florida Amendment 2, doctors should be able to order it for patients,  but there’s a possible hurdle in the way.

There’s a push to have each case go before the Florida Board of Medicine first.

“The board of medicine is not in the consultation with us, they’re not assessing patients one on one like we are.”, said pediatrician Dr. David Berger.

Berger explains that patients with Autism suffer from similar symptoms as people with PTSD, who are now eligible for medical marijuana under the “Compassionate Care Act”.

GW Pharmaceuticals is hoping to develop a treatment for cancer after announcing promising results from an early stage study looking at how its cannabis-based molecules can help patients with the disease.

The trial tested how safe and effective two of GW's cannabis-derived molecules were in 21 patients suffering from glioblastoma multiforme (GBM), an aggressive type of brain tumour.

The results showed that patients treated with GW's drug, in combination with temozolomide, which is the current medication used to treat GBM, had an 83pc one-year survival rate, compared with 53pc for patients in the placebo cohort.

The combination therapy increased median survival to more than 550 days, compared with 369 days for those on the placebo.

Synthetic marijuana compounds, sometimes called K2 or Spice, are actually chemically different from marijuana, and are more dangerous than pot, according to a new review of studies.

Synthetic marijuana compounds are linked to a number of serious side effects, including seizures, psychosis and even death, the review's authors said.

Israeli ministers on Sunday endorsed a draft bill to legalise export of cannabis for approved medical use, Justice Minister Ayelet Shaked's office said, without elaborating.

Adoption by the ministerial committee on legislation, which meets outside the full cabinet, means that the draft will now move forward as a government bill.

No date was set for a first reading.

Shaked's office said that a scheduled debate on decriminalising marijuana use in favour of fines and treatment was put back until next Sunday.

Although the recreational use of cannabis is currently illegal in the Jewish state, for the past 10 years its therapeutic use has not only been permitted but encouraged.